Article ID Journal Published Year Pages File Type
3269621 HPB 2010 7 Pages PDF
Abstract
Borderline resectable pancreatic tumours can be treated neoadjuvantly, resulting in margin-negative resection and survival rates similar to those in initially resectable disease.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Preview
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer
Authors
, , , , , ,